At what pace is the drug and gene delivery devices market growing, and what is its estimated value?
The drug and gene delivery devices market size has grown strongly in recent years. It will grow from $0.61 $ billion in 2024 to $0.67 $ billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to healthcare infrastructure development, expansion of personalized gene therapy programs, increasing focus on preventive healthcare, rare and orphan diseases, and increasing public awareness about health and treatment options.
The drug and gene delivery devices market size is expected to see strong growth in the next few years. It will grow to $0.93 $ billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to the increasing incidence of chronic diseases, growing demand for personalized medicine, increasing awareness and adoption of gene therapy, demand for non-invasive and minimally invasive procedures, and the growing popularity of direct-to-patient delivery models. Major trends in the forecast period include advancements in biotechnology and genetic engineering, technological advancements in drug delivery systems, increasing investment in research and development, the development of novel delivery platforms, and advancements in diagnostic technologies.
Get Your Free Sample of The Global Drug And Gene Delivery Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19404&type=smp
What are the top drivers to the rising demand in the drug and gene delivery devices market?
The increasing adoption of gene therapy is expected to propel the growth of the drug and gene delivery devices market going forward. Gene therapy is a medical technique that involves the introduction, removal, or alteration of genetic material within a patient’s cells to treat or prevent disease. Gene therapy demand is rising due to its potential to cure genetic disorders and chronic diseases at their root causes, offering transformative treatment options where conventional therapies fall short. Drug and gene delivery devices are essential in gene therapy for precise targeting and controlled release of therapeutic genes, enhancing treatment efficacy. For instance, in November 2023, according to the National Centre for Biotechnology Information, a US-based resource for the scientific research community, the expected number of new patients treated with gene therapies will grow from 16,244 in 2020 to 94,696 in 2025. Therefore, the increasing adoption of gene therapy is driving the growth of the drug and gene delivery devices market.
How is the drug and gene delivery devices market segmented?
The drug and gene delivery devicesmarket covered in this report is segmented –
1) By Vector: Viral, Non-viral
2) By Method: In Situ, Ex Vivo
3) By Route Of Administration: Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical
Subsegments:
1) By Viral: Adenovirus Vectors, Lentivirus Vectors, Adeno-Associated Virus (AAV) Vectors, Herpes Simplex Virus (HSV) Vectors, Retrovirus Vectors, Baculovirus Vectors, Vaccinia Virus Vectors, Sendai Virus Vectors
2) By Non-Viral: Lipid Nanoparticles (LNP), Polymeric Nanoparticles, Liposomes, Dendrimers, Naked DNA/RNA Delivery, Electroporation-Based Delivery Systems, Nanoparticle-Based Delivery Systems, Polymer Micelles And Hydrogels.
Order your report now for swift delivery
Who are the top competitors in the drug and gene delivery devices market?
Major companies operating in the drug and gene delivery devices market are Merck & Co. Inc., AbbVie Inc., Bayer AG, AstraZeneca plc, Medtronic plc, Amgen Inc., Moderna Inc., Biogen Inc., Sarepta Therapeutics Inc., SCIEX, Halozyme Therapeutics Inc., ViiV Healthcare Limited, Uniqure NV, Cytokinetics Inc., Prothena Corporation plc, Intellia Therapeutics Inc., Voyager Therapeutics Inc., sfm medical devices GmbH, Inovio Pharmaceuticals Inc., GenSight Biologics S.A., CRISPR Therapeutics
What significant trends should we anticipate in the drug and gene delivery devices market over the forecast period?
Major companies operating in the drug and gene delivery devices market are focusing on developing advanced products, such as artificial intelligence (AI) technology, to gain a competitive edge in the market. Artificial intelligence (AI) technology in drug delivery refers to the application of AI techniques and algorithms to improve the efficiency, precision, and effectiveness of drug delivery systems. For instance, in December 2023, Envoya Inc., a US-based developer of polymer-based nanoparticles for targeted delivery, launched an innovative gene therapy drug delivery platform. This platform combines biopolymer-nanoparticles with artificial intelligence (AI) to address significant limitations in current gene therapy technologies, such as viral vectors and lipid nanoparticles. The platform aims to overcome the limitations of existing gene therapy delivery technologies, which have been restricted by safety concerns, limited payload capacities, and limited tissue targeting.
Which regional trends are influencing the drug and gene delivery devices market, and which area dominates the industry?
North America was the largest region in the drug and gene delivery devices market in 2024. The regions covered in the drug and gene delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Drug And Gene Delivery Devices Market Report 2025 Offer?
The drug and gene delivery devices market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Drug and gene delivery devices are tools designed to transport pharmaceuticals or genetic material into the body for therapeutic purposes, enabling targeted treatment of diseases at the molecular level with enhanced precision and efficacy. These devices are crucial in advancing personalized medicine by ensuring controlled release and optimal delivery of therapeutic agents to specific cells or tissues, minimizing side effects, and maximizing treatment effectiveness.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19404
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
